Business News • PR NewsWire • Groundbreaking Study Showed Bayer's Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain

Groundbreaking Study Showed Bayer's Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain

Groundbreaking Study Showed Bayer's Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain

SHAWNEE, Kan. Jan. 16, 2011 /PRNewswire/ -- In a new comparative study evaluating the efficacy of four leading heartworm preventives, only Bayer's Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was 100 percent effective after a single treatment against the MP3 strain of

View More : http://www.prnewswire.com/news-releases/groundbreaking-study-showed-bayers-advantage-multi-for-dogs-imidacloprid--moxide...

Releted News by prnewswire

VIDEO from Velux Available on thenewsmarket.com: Velux 5 Oceans Round The World Yacht Race - Brad Van Liew Takes Victory in Ocean Sprint 2

Rentrak Announces Official Box Office Totals for Weekend of January 14, 2011

Program Release of the DLD Conference 2011 "Update your Reality"

New EU Agency Report on Governmental Cloud Computing Security in EU